A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting

PHASE3CompletedINTERVENTIONAL
Enrollment

304

Participants

Timeline

Start Date

October 1, 2015

Primary Completion Date

April 5, 2017

Study Completion Date

April 5, 2017

Conditions
Bladder Cancer
Interventions
DRUG

Hexaminolevulinate hydrochloride

Instillation in bladder

DEVICE

KARL STORZ D-Light C PDD Flexible Videoscope System

Cystoscopy procedure

Trial Locations (17)

10016

NYU Langone Urology Associates, New York

10032

Columbia University Medical Center, New York

10197

Thomas Jefferson University, Philadelphia

10461

Montefiore Medical Center, The Bronx

21205

Johns Hopkins University, Baltimore

27599

University of North Carolina, Department of Urology, Chapel Hill

37232

Vanderbilt University Medical Center, Nashville

43210

Ohio State University The James Cancer Hospital, Columbus

52242

University of Iowa, Iowa City

53792

University of Wisconsin, Madison

55455

University of Minnesota, Minneapolis

60637

University of Chicago Medical Center, Chicago

73104

University of Oklahoma-Stephenson Cancer Center, Oklahoma City

75390

UT Southwestern Medical Center, Dallas

77030

MD Anderson Cancer Center, Houston

Michael E. DeBakey VA Medical Center, Houston

90033

USC Norris Comprehensive Cancer Center, Los Angeles

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

KARL STORZ Endoscopy-America, Inc.

INDUSTRY

lead

Photocure

INDUSTRY